Status:
COMPLETED
Bupivacaine 5 mg vs 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population
Lead Sponsor:
Indonesia University
Conditions:
Cesarean Section
Hypotension Drug-Induced
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
This study aims to evaluate the efficacy of hyperbaric 5 mg bupivacaine + fentanyl 25 mcg versus hyperbaric 7.5 mg bupivacaine + fentanyl 25 mcg to lower incidence of hypotension
Detailed Description
Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired prior conducting the study. Subjects will be recruited using consecutive sampling method. Sample size was dete...
Eligibility Criteria
Inclusion
- pregnant women with ASA PS 1-3
- age 18-40 years old
- in an elective or emergency cesarean delivery using spinal anesthesia
Exclusion
- patients with contraindication of spinal anesthesia
- have history of allergy to bupivacaine or fentanyl
- with eclampsia
- valvular heart disease
- congenital heart disease
- coronary heart disease
- twin pregnancy
- morbid obesity (BMI \>=40)
- pre-partum hemorrhage with hemodynamic instability
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2013
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT03834454
Start Date
October 1 2013
End Date
December 31 2013
Last Update
February 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, Indonesia, 10430